CellChorus operates in the biotechnology sector, specializing in dynamic single cell analysis. The company's core technology, Time-lapse Imaging Microscopy in Nanowell Grids (TIMING), utilizes visual AI to evaluate cell behavior in various environments. This platform is adaptable to different cell types and applications, including tumor infiltrating lymphocytes, T cell receptors, natural killer cells, monoclonal antibodies, and chimeric antigen receptor T cells. CellChorus serves research institutions, pharmaceutical companies, and biotech firms by providing detailed insights into cellular functions, states, and phenotypes. The business model revolves around offering advanced analytical services and licensing its proprietary technology. Revenue is generated through service contracts, technology licensing, and collaborative research agreements. The TIMING platform enables the identification and retrieval of cells for further profiling, such as RNA sequencing and protein expression, providing clients with a comprehensive understanding of cellular interactions and kinetics.

Keywords: dynamic single cell analysis, AI-driven imaging, TIMING platform, cellular insights, biotechnology, tumor infiltrating lymphocytes, T cell receptors, natural killer cells, monoclonal antibodies, chimeric antigen receptor T cells.